Historic Go-ahead for Malaria Vaccine To Protect African Children

DEAD7

Veteran
Supporter
Joined
Oct 5, 2012
Messages
51,114
Reputation
4,515
Daps
89,229
Reppin
Fresno, CA.
Historic Go-ahead for Malaria Vaccine To Protect African Children



Malaria has been one of the biggest scourges on humanity for millennia and mostly kills babies and infants. Having a vaccine -- after more than a century of trying -- is among medicine's greatest achievements. The vaccine -- called RTS,S -- was proven effective six years ago. Now, after the success of pilot immunisation programmes in Ghana, Kenya and Malawi, the World Health Organization says the vaccine should be rolled out across sub-Saharan Africa and in other regions with moderate to high malaria transmission. Dr Tedros Adhanom Ghebreyesus, director-general of the WHO said it was "a historic moment." "The long-awaited malaria vaccine for children is a breakthrough for science, child health and malaria control." Using the vaccine on top of existing tools "could save tens of thousands of young lives each year," he said.
 

get these nets

Veteran
Joined
Jul 8, 2017
Messages
56,522
Reputation
15,640
Daps
209,093
Reppin
Above the fray.


07/09/25

Hope for developing world as Swiss anti-malarial for newborns approved​

Wednesday 09 July 2025

Related: Malaria vaccine approved
  • Switzerland's medical products authority, Swissmedic, has granted the first approval for a malaria medicine specifically designed for infants weighing between 2 and 5kg.
  • The newly approved medication, developed by Novartis, is a lower-dose version of a tablet previously approved for older age groups.
  • Swissmedic's decision is significant as it marks only the third time the agency has used a fast-track authorisation process, in coordination with the World Health Organization, to help developing countries access needed treatment.
  • This development is crucial given that malaria remains the deadliest disease in Africa, accounting for 95 per cent of global deaths from the disease in 2023, with children account for over three-quarters of those deaths.
  • While welcomed, experts highlight the importance of transparency regarding Novartis's planned “largely not-for-profit” rollout, including pricing and distribution strategies, especially as malaria cases continue to rise and drug resistance grows.
 
Top